In brief: Tactile Systems buys LymphaTech, AAH shows impact, Numotion settles lawsuit
By HME News Staff
Updated 9:30 AM CST, Wed February 25, 2026
MINNEAPOLIS – Tactile Systems Technology has acquired LymphaTech for an upfront cash payment at closing of $6.8 million, plus potential additional consideration that is contingent upon the achievement of future milestones.
The acquisition will expand Tactile Medical’s lymphedema portfolio with new solutions that enable more accurate and efficient disease identification and progression, while broadening the company’s research and development capabilities and strengthening its market leadership position in conditions associated with lymphatic dysfunction.
“This acquisition is a milestone in Tactile’s evolution from a product-based company to a comprehensive, integrated solutions leader for lymphatic dysfunction,” said Sheri Dodd, CEO of Tactile Medical. “By bringing together Tactile and LymphaTech, we become uniquely positioned to support patients and clinicians from early disease intervention to innovative connected therapies with long-term support and monitoring alongside our Kylee patient engagement application.”
LymphaTech’s primary technology is a hand-held, clinically validated solution that uses proprietary algorithms and mobile scanning to deliver highly accurate fluid volume and precise circumference measurements, two critical elements in identifying lymphedema and informing the appropriate therapy options. The platform immediately generates a clinical grade 3D model of the body and limbs, replacing traditional manual measurement methods that are time consuming and highly variable.
In connection with the transaction, LymphaTech co-founders Mike Weiler and Nate Frank have joined Tactile Medical to drive commercial adoption of the LymphaTech platform and support ongoing research activities.
AAHomecare releases 2025 impact report showcasing accomplishments
ARLINGTON, Va. – AAHomecare has released its 2025 Impact Report, offering an inside look at how coordinated advocacy and collaboration shaped policy outcomes during one of the most challenging years the industry has faced.
The report highlights the advocacy, joint efforts and industry-wide initiatives that shaped reimbursement, access to care and day-to-day operations.
“In 2025, access to home-based care was tested, but the strength of a united industry was on full display,” said Tom Ryan, president & CEO of AAHomecare. “Our members rose to meet these challenges, and the report reflects what’s possible when collaboration, advocacy and expertise translate into real-world results for the HME community and those we serve.”
Key takeaways from the report include:
- Coordinated federal and state advocacy helped secure competitive bidding legacy product exclusions, CMS regulatory improvement and state actions protecting Medicaid DME access.
- Members leveraged AAHomecare’s 33 member-led councils and groups, working alongside consumer and clinician allies to respond quickly to emerging policy and operational challenges.
- New resources – including a payer transparency portal, the industry’s first mini-documentary and educational tools – helped HME stakeholders communicate value to policymakers, payers, and the public.
- With the return of competitive bidding for select products and ongoing Medicaid reimbursement pressures, the report highlights where collective industry action is making a difference and where sustained engagement will be critical.
AAHomecare invites all members of the HME community – whether current members or those considering joining – to explore the report and see how the association is advancing the industry, delivering value to its members and strengthening the industry’s ability to provide exceptional home-based care to millions of people.
“At its core, this report is a testament to the power of community, united around a shared purpose,” said Ashley Plauché, senior director of brand marketing. “Our members and partners advocate tirelessly, support one another, and contribute to tangible outcomes. It’s inspiring to see the results of this collaboration in action.”
CMS proposes denying coverage for seat elevation systems on Group 2 power wheelchairs
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has published a proposed local coverage determination (LCD) for a not reasonable and necessary determination for Group 2 power wheelchairs (PWCs) with seat elevation systems (K0830 and K0831) based on the best available evidence.
The agency states, per the national coverage determination (NCD) for seat elevation equipment (power operated) on power wheelchairs, coverage of Group 2 PWCs with seat elevators would be determined at the MAC’s discretion.
The National Coalition for Assistive & Rehab Technology (NCART) had this response to the news:
“On February 19th, nearly three years after the Centers for Medicare & Medicaid Services (CMS) affirmed Medicare coverage for power seat elevation on power wheelchairs, the Medicare DME MACs announced proposed changes to the Power Mobility Device Local Coverage Determination that states, Group 2 PWC with seat elevation systems (K0830, K0831) will be denied as not reasonable and necessary,” the organization stated in a bulletin. “NCART has formed a stakeholder workgroup to develop evidence-based information for physicians, clinicians, manufacturers, providers and beneficiaries to submit comments on the impact this proposal will have on access to medically necessary care. We ask all stakeholders to hold off submitting comments on this until we have completed a detailed analysis of the proposed change and communicated that to all interested parties with a clear and coordinated message.”
CMS will accept comments on the proposed LCD until April 4, 2026.
Option Care looks to capitalize on growth trends
BANNOCKBURN, Ill. – Option Care Health reported net revenue of $1.465 billion for the fourth quarter ended Dec. 31, 2025, an increase of 8.8% over the prior year. Net revenue for the full year was $5.65 billion, up 13%.
Adjusted EBITDA for the quarter was $126 million, up 3.7%, and $473 million for the full year up 6.2%, year over year.
“Our team continued to execute at a very high level to deliver extraordinary care and solid results in the fourth quarter and full year of 2025,” said John Rademacher, CEO. “During 2025, we served over 315,000 patients and they remain at the center of everything we do. We continued to make significant progress against our key priorities to build a sustainable growth enterprise while navigating a dynamic industry environment. As we look ahead in 2026, I am excited about the opportunities to further our mission and capitalize on the positive long-term growth trends across our industry and the strength of our position to serve more patients.”
The company provided the following full-year 2026 financial guidance:
- Net revenue of $5.8 billion to $6.0 billion.
- Adjusted EBITDA of $480 million to $505 million.
Numotion settles data incidents
NASHIVILLE, Tenn. – A settlement has been reached in a class action lawsuit against United Seating and Mobility, d/b/a Numotion, relating to two data incidents in 2024.
According to a court-authorized settlement website:
- During a March 2024 data incident, an unauthorized individual accessed certain of defendant’s systems, which may have included private information belonging to defendant’s former and current customers and employees; and
- During a September 2024 data incident, an unauthorized individual accessed certain user accounts within defendant’s environment, in which personal health information may have been impacted.
Numotion denies any liability or wrongdoing, and the court has not decided that defendant did anything wrong. The parties have agreed to settle the actions to avoid the risks, disruption and uncertainties of continued litigation.
Members of the settlement are eligible to receive:
- Cash payment A - documented out-of-pocket losses: Members may submit a claim, with supporting documentation, showing they spent money or incurred losses related to the March 2024 data incident or the September 2024 data incident, that are fairly traceable to the March 2024 data incident or September 2024 data incident, up to $15,000 per member.
- Cash payment B - pro rata cash: Members may submit a claim for a cash payment.
All members will also receive:
- Two years of CyEx Identity Defense Plus (“credit monitoring”).
- May also submit a claim for two years of CyEx Medical Shield Pro (“medical monitoring”).
Pride Mobility Products makes two promotions at Quantum Rehab
DURYEA, Pa. – Pride Mobility Products has promoted Jay Brislin and David Bertz to senior vice presidents at Quantum Rehab. “Together, Jay and David represent a leadership model ensuring Quantum USA continues to evolve alongside the providers, clinicians and consumers it serves,” said Scott Meuser, CEO of Pride Mobility Products. “With a shared focus on continuous improvement, their leadership reflects Quantum’s belief that the best way forward is to keep getting better — and that Jay and David are the right leaders to make that happen.”
- About Brislin: He has more than 25 years of industry experience and has built and led Quantum’s educational and sales teams. “I am truly grateful to be part of such an exceptional organization, made up of passionate people who are committed to delivering the highest level of customer experience, product innovation, and consumer satisfaction,” he said.
- About Bertz: He has focused on supporting customers and sales, and building high-performance sales teams. “I’m humbled to be part of a team whose success is driven by a people-first culture grounded in being humble, hungry, and smart, with a singular focus on the consumer experience in power mobility,” he said. “By listening closely to consumers, clinicians and ATPs — and remaining 100% focused on power mobility — we deliver solutions that meet real user needs today and will continue to raise the standard through our future product roadmap.”
Reps reintroduce Wigs as Durable Medical Equipment Act
WASHINGTON – Reps. Jim McGovern, D-Mass., and Ayanna Pressley, D-Mass., alongside Sen. Richard Blumenthal, D-Conn., have reintroduced the Wigs as Durable Medical Equipment Act, a bill that would require Medicare to cover wigs for individuals affected by alopecia and patients undergoing chemotherapy. Currently, many private insurance plans cover wigs for those undergoing treatments that cause hair loss or who are affected by alopecia areata, but Medicare does not. “For people impacted by alopecia or undergoing cancer treatment, a wig can make a major difference—providing them with the confidence and courage to live as normally as possible during a challenging time,” McGovern said. “But wigs can cost thousands of dollars, and despite the enormous and clear benefits they provide, Medicare doesn’t currently cover them. That needs to change. This bill is about helping make sure everyone can live their lives with dignity and confidence, regardless of who they are or how much money is in their bank account. Everyone deserves to be treated with respect, and that is what this bill is about.” Alopecia areata is an autoimmune skin disease, with no known cause or cure, affecting approximately 6.9 million Americans. The disease disproportionately affects children and Black Americans, particularly Black women. Many individuals affected by Alopecia Areata use wigs as there are currently few effective treatment options. Unfortunately, these prosthetics can come with a significant out-of-pocket cost from $100 to several thousand dollars for individuals with low or fixed incomes. This is especially burdensome for children, who often want cranial prosthetics for attending school.
Fisher & Paykel Healthcare raises guidance
AUCKLAND, New Zealand – Fisher & Paykel Healthcare now expects full-year operating revenue to be about $2.3 billion, and net profit after tax to be in the range of about $450 million to $470 million. Previously, the company said it expected operating revenue in the range of about $2.17 billion to $2.27 billion and full-year net profit after tax of about $410 million to $460 million. “While relative seasonal respiratory hospitalizations in the Northern Hemisphere winter may continue to impact the second half result, our performance to date suggests pleasing progress in our efforts to change clinical practice,” said Lewis Gradon, managing director and CEO. “Continuous improvement activities and other efficiency gains are also contributing to improvements in our gross margin and operating margin.” F&P Healthcare says the updated guidance does not incorporate any potential refund of U.S. tariffs paid to date during the 2026 financial year, following the U.S. Supreme Court’s decision to invalidate tariffs imposed by the administration under the International Emergency Economic Powers Act. The company says it continues to work through the complexities associated with the court ruling, refund processes and application of free trade agreements and the Nairobi Protocol to its products, and will provide an update on tariff impacts with its full-year results at the end of May.
TBO adds managed care expert to team, expanding services for HME providers
LAS VEGAS – Tactical Back Office (TBO) has added Lauren Barranti to its team, adding managed care and growth strategy expertise to its health care platform. With more than 20 years of health care experience, Barranti brings deep experience across home care, managed care and medical supply organizations, with a particular focus on the California at-risk medical group market. Her background includes serving as CEO of California Home Medical Equipment, vice president of managed care at Apria and business development director at Baxter. She is also principal at AllRevup Healthcare Solutions, where she has advised health care organizations on value-based contracting, payer strategy and sustainable revenue growth. “TBO clients are asking for more than staffing,” said Todd Usher, president and founder of TBO. “They need infrastructure that supports growth without breaking under reimbursement pressure. Lauren has operated on every side of the equation – provider, operator and executive. By integrating her expertise into TBO, we’re giving health care organizations access to managed care and growth strategy that actually gets implemented.” Barranti’s expertise will be delivered directly to clients as part of TBO’s health care operating model. Her work will intersect with TBO’s trained back-office teams to support value-based capitation agreements, payer strategy and competitive differentiation analysis, as well as go-to-market planning for durable medical equipment, diagnostic and medical supply organizations. Barranti’s focus will be on not only advisory recommendations but also execution that can be supported, monitored and sustained operationally, the company says. “I’ve spent my career helping health care organizations turn complexity into operational advantage,” she said. “What drew me to Tactical Back Office is the discipline behind their execution. This model connects strategy to real workflows, teams, and accountability — which is where growth either succeeds or fails.
Home Oxygen Company plugs in with all-electric delivery fleet
MODESTO, Calif. – Home Oxygen Company has transitioned its entire delivery fleet to all-electric Chevrolet BrightDrop Zevo vans, strengthening delivery reliability and operational consistency across its home medical equipment (HME) services. By standardizing delivery operations around purpose-built electric vehicles, Home Oxygen Company is reducing variability across its delivery footprint and increasing control over response time, routing and performance accountability, the company says.“For us, this decision is about stewardship,” said Andrea Ewart, president of Home Oxygen Company. “A reliable fleet is foundational to how we operate. These vehicles help us respond faster, operate more consistently, and meet our responsibility to the people and communities who depend on our services.” The BrightDrop Zevo is a fully electric commercial van designed for last-mile delivery. Home Oxygen Company has configured the vehicles specifically for transporting home medical equipment, pairing cargo optimization with modern fleet tracking and monitoring systems. The result is interruption-resistant delivery supported by real-time visibility and performance data, the company says.
InfuSystem ‘makes advances,’ building on tech investments
ROCHESTER HILLS, Mich. - InfuSystem Holdings reported revenue of $36.2 million for the fourth quarter and $143.4 million for the full year ended Dec. 31, 2025, increases of 7% and 6%, respectively, compared to the prior year. Patient Services net revenue was $21.9 million for the quarter, and Device Solutions net revenue was $14.4 million for the quarter. For the full year, Patient Services revenue $86.5 million and Device Solutions was $86.9 million. "During the fourth quarter we continued to make advances on key initiatives that are expected to deliver on our clear mandate to execute with discipline, deliver profitable growth and drive long-term value creation for our shareholders," said Carrie LaChance, CEO. "We made significant progress on our new revenue cycle management platform, which is already lowering claims processing costs and improving billing efficiency, and on our enterprise technology upgrade, which is expected to go live at the end of the first quarter of 2026. We also established new relationships with home healthcare durable medical equipment ("DME") manufacturers. I’m confident that our focus and progress on these initiatives will help us build on the margin expansion and cash flow improvements we delivered in 2025." InfuSystem is providing annual net revenue guidance for the full year 2026 in two parts by providing the impact of the biomedical services contract restructuring, which will reduce our net revenues by $7.1 million, or 5.5%, separately from the pro-forma growth rate for the unaffected business. This pro-forma net revenue growth is estimated to be between 6% to 8% for 2026. The company is also forecasting adjusted EBITDA margin (non-GAAP) to be in the mid to low 20%s. This includes the planned reduction in the implementation expenses for the company's upgraded information technology systems, which are expected to go online at the end of the first quarter of 2026. The company intends to update its annual guidance throughout the year.
Comments